Wednesday, November 25, 2009, 9:09am EST - Canadian Markets open in 21 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

CombiMatrix Corporation (CBMX)

 On Nov 24: 6.10 USD   0.00 (0.00%)  
MORE ON CBMX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CombiMatrix Corporation (NGM:CBMX) Delayed quote dataEdit
Last Trade: 6.10 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 6.10
Open: N/A
Bid: 4.88 x 100
Ask: 6.38 x 1000
1y Target Est: 15.50
Day's Range: N/A - N/A
52wk Range: 5.09 - 10.05
Volume: 0
Avg Vol (3m): 14,295.5
Market Cap: 46.18M
P/E (ttm): N/A
EPS (ttm): -2.67
Div & Yield: N/A (N/A%)
CombiMatrix Corporation (CBMX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CBMX to Portfolio   Download Data

HEADLINES
• COMBIMATRIX CORP Financials
EDGAR Online Financials (Thu, Nov 19)
• COMBIMATRIX CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• COMBIMATRIX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 12)
• New Star Analyst Rankings for CombiMatrix Corporation
StarMine (Thu, Nov 12)
• CombiMatrix Corporation Third Quarter Financial Results Call scheduled for 4:30 pm ET today
Shareholder.com (Wed, Nov 11)
• Q3 2009 CombiMatrix Corporation Earnings Release - After Market Close
CCBN (Wed, Nov 11)
• CEO Interview: CombiMatrix Corporation - Dr. Amit Kumar
Wall Street Transcript (Tue, Oct 20)
• COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Mon, Oct 5)
• COMBIMATRIX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Mon, Sep 14)
• COMBIMATRIX CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
More Headlines for CBMX...
ANALYST
EPS Est (next year) (Dec-09) : -2.73
EPS Est (in 2 years) (Dec-10) : -2.05
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
CombiMatrix Corporation, together with its subsidiaries, develops technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology, defense, and homeland security.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices